Research ArticleOriginal Research

Intrapartum Antibiotics and Childhood Atopic Dermatitis

Debra L. Wohl, William J. Curry, Dave Mauger, Jennifer Miller and Kaitlyn Tyrie
The Journal of the American Board of Family Medicine January 2015, 28 (1) 82-89; DOI: https://doi.org/10.3122/jabfm.2015.01.140017

References

  1. 1.↵
    1. Warmer JO
    . Worldwide variations in the prevalence of atopic symptoms: what does it all mean? Thorax 2007;54:S46–51.
    OpenUrl
  2. 2.↵
    ISAAC. Worldwide variation in prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and atopic eczema: ISAAC. The International Study of Asthma and Allergies in Childhood (ISAAC) Steering Committee. Lancet 1998;351:1225–32.
    OpenUrlCrossRefPubMedWeb of Science
  3. 3.↵
    1. Williams HC
    1. Williams HC
    . What is atopic dermatitis and how should it be defined in epidemiological studies? In: Williams HC, editor. Atopic dermatitis: the epidemiology, causes, and prevention of atopic eczema. Cambridge (UK): Cambridge University Press; 2000:3–24.
  4. 4.↵
    1. Kinross JM,
    2. Darzi AW,
    3. Nicholson JK
    . Gut microbiome-host interactions in health and disease. Genome Med 2011;3:14.
    OpenUrlCrossRefPubMed
  5. 5.↵
    1. Bakhead F
    . Host responses to the human microbiome. Nutr Rev 2012;70:S14–7.
    OpenUrlCrossRef
  6. 6.↵
    1. Cho I,
    2. Blaser MJ
    . The human microbiome: at the interface of health and disease. Nat Rev Genet 2012;13:260–70.
    OpenUrlCrossRefPubMed
  7. 7.↵
    1. Bjorksten B,
    2. Sepp E,
    3. Julge K,
    4. Voor T,
    5. Mikelsaar M
    . Allergy development and the intestinal microflora during the first year of life. J Allergy Clin Immun 2011;108:516–20.
    OpenUrl
  8. 8.↵
    1. Bottcher MF,
    2. Nordin EK,
    3. Sandin A,
    4. Midtvedt T,
    5. Bjorksten B
    . Microflora-associated characteristics in faeces from allergic and non-allergic infants. Clin Exper Allergy 2000;30:1591–6.
    OpenUrl
  9. 9.↵
    1. Isolauri E,
    2. Sutas Y,
    3. Kankaanpaa P,
    4. Arvilommi H,
    5. Salminen S
    . Probiotics: effects on immunity. Am J Clin Nutr 2001;73:444S–50S.
    OpenUrlAbstract/FREE Full Text
  10. 10.↵
    1. Kalliomaki M,
    2. Kirjavainen P,
    3. Eerola E,
    4. Kero P,
    5. Salminen S,
    6. Isolauri E
    . Distinct patterns of neonatal gut microflora in infants in whom atopy was and was not developing. J Allergy Clin Immun 2001;107:129–34.
    OpenUrlCrossRefPubMedWeb of Science
  11. 11.↵
    1. McKeever TM,
    2. Lewis SA,
    3. Smith C,
    4. Hubbard R
    . The importance of prenatal exposures on the development of allergic disease. Am J Respir Crit Care Med 2002;166:827–32.
    OpenUrlCrossRefPubMedWeb of Science
  12. 12.↵
    1. Dom S,
    2. Droste JHJ,
    3. Sariachvili MA,
    4. et al
    . Pre- and post-natal exposure to antibiotics and the development of eczema, recurrent wheezing and atopic sensitization in children up to the age of 4 years. Clin Exp Allergy 2010;40:1378–87.
    OpenUrlCrossRefPubMedWeb of Science
  13. 13.↵
    1. Alm JS,
    2. Swartz J,
    3. Lilja G,
    4. Scheynius A,
    5. Pershagen G
    . Atopy in children of families with an anthroposophic lifestyle. Lancet 1999;353:1485–8.
    OpenUrlCrossRefPubMedWeb of Science
  14. 14.↵
    1. Droste JH,
    2. Wieringa MH,
    3. Weyler JJ,
    4. Nelen VJ,
    5. Vermoirc PA,
    6. Van Bever HP
    . Does the use of antibiotics in early childhood increase the risk of asthma and allergic disease? Clin Exp Allergy 2000;30:1547–53.
    OpenUrlPubMedWeb of Science
  15. 15.↵
    1. McKeever T,
    2. Lewis SA,
    3. Smith C,
    4. et al
    . Early exposure to infections and antibiotics and the incidence of allergic disease: a birth cohort study with the West Midlands General Practice Research Database. J Allergy Clin Immun 2002;109:43–50.
    OpenUrlCrossRefPubMedWeb of Science
  16. 16.↵
    1. Negele K,
    2. Heinrich J,
    3. Borte M,
    4. et al
    .; LISA Study Group. Mode of delivery and development of atopic disease during the first 2 years of life. Pediatr Allergy Immunol 2004;15:48–54.
    OpenUrlCrossRefPubMedWeb of Science
  17. 17.↵
    1. Falk PG,
    2. Hooper LV,
    3. Midtvedt T,
    4. Gordon JI
    . Creating and maintaining the gastrointestinal ecosystem: what we know and need to know from gnotobiology. Microbiol Mol Biol Rev 1998;62:1157–70.
    OpenUrlAbstract/FREE Full Text
  18. 18.↵
    1. Kero J,
    2. Gissler M,
    3. Gronlund M,
    4. et al
    . Mode of delivery and asthma – is there a connection? Pediatr Res 2002;52:6–11.
    OpenUrlCrossRefPubMedWeb of Science
  19. 19.↵
    1. Hakansson S,
    2. Kallen K
    . Caesarean section increases the risk of hospital care in childhood for asthma and gastroenteritis. Clin Exp Allergy 2003;33:757–64.
    OpenUrlCrossRefPubMedWeb of Science
  20. 20.↵
    1. Cheng Q,
    2. Nelson D,
    3. Zhu S,
    4. Fishchetti VA
    . Removal of group B Streptococci colonizing the vagina and oropharynx of mice with a bacteriophage lytic enzyme. Antimcrob Agents Chemother 2005;49:111–7.
    OpenUrlAbstract/FREE Full Text
  21. 21.↵
    1. Easmon C,
    2. Hastings M,
    3. Deeley J,
    4. Bloxham B,
    5. Rivers R,
    6. Marwood R
    . The effect of intrapartum chemoprophylaxis on the vertical transmission of group B streptococci. Br J Obstet Gynaecol 1983;90:633–5.
    OpenUrlPubMedWeb of Science
  22. 22.↵
    1. Mackay G,
    2. House M,
    3. Bloch E,
    4. Wolfberg A
    . A GBS culture collected shortly after GBS prophylaxis may be inaccurate. J Matern Fetal Neonatal Med 2012;25:736–8.
    OpenUrlPubMed
  23. 23.↵
    1. Penders J,
    2. Stobberingh EE,
    3. Thijs C,
    4. et al
    . Molecular fingerprinting of the intestinal microbiota of infants in whom atopic eczema was or was not developing. Clin Exp Allergy 2006;36:1602–8.
    OpenUrlCrossRefPubMed
  24. 24.↵
    1. Farooqi IS,
    2. Hopkin JM
    . Early childhood infection and atopic disorder. Thorax 1998;53:927–32.
    OpenUrlAbstract/FREE Full Text
  25. 25.↵
    1. Dominguez-Bello MG,
    2. Costello EK,
    3. Contreras M,
    4. et al
    . Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body habitats in newborns. Proc Natl Acad Sci U S A 2010;107:11971–5.
    OpenUrlAbstract/FREE Full Text
  26. 26.↵
    1. Bahrami B,
    2. Macfarlane S,
    3. Macfarlane GT
    . Induction of cytokine formation by human intestinal bacteria in gut epithelial lines. J Appl Microbiol 2010;110:353–63.
    OpenUrl
  27. 27.↵
    1. Verani JR,
    2. McGee L,
    3. Schrag SJ
    ; Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention (CDC). Prevention of perinatal group B streptococcal disease–revised guidelines from CDC, 2010. MMWR Recomm Rep 2010;59(RR-10):1–36.
    OpenUrlPubMed
  28. 28.↵
    1. Lin FYC,
    2. Brenner RA,
    3. Johnson YR,
    4. et al
    . The effectiveness of risk-based intrapartum chemoprophylaxis for the prevention of early-onset neonatal group b streptococcal disease. Amer J Obstet Gynecol 2001;184:1204–10.
    OpenUrlCrossRefPubMedWeb of Science
  29. 29.↵
    1. Moore MM,
    2. Rifas-Shiman SL,
    3. Rich-Edwards JW,
    4. et al
    . Perinatal predictors of atopic dermatitis occurring in the first six months of life. Pediatrics 2004;113:468–74.
    OpenUrlAbstract/FREE Full Text
  30. 30.↵
    1. Strachan DP
    . Hay fever, hygiene, and household size. British Med J 1989;299:1259–60.
    OpenUrlFREE Full Text
  31. 31.↵
    1. Rautava S,
    2. Ruuskanen O,
    3. Ouwehand A,
    4. Salminen S,
    5. Isolauri E
    . The hygiene hypothesis of atopic disease – an extended version. J Pediatr Gastroenterol Nutr 2004;38:378–88.
    OpenUrlCrossRefPubMedWeb of Science
  32. 32.↵
    1. Tessler R
    . Birth order, family size, and children's use of physician services. Health Serv Res 1979;3:55–62.
    OpenUrl
  33. 33.↵
    1. Chen AY,
    2. Escarce JJ
    . Effects of family structure on children's use of ambulatory visits and prescription medications. Health Serv Res 2006;41:1895–914.
    OpenUrlCrossRefPubMedWeb of Science
  34. 34.↵
    1. Palmer CN,
    2. Irvine AD,
    3. Terron-Kwiatkowski A,
    4. et al
    . Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis. Nat Genet 2006;38:441–6.
    OpenUrlCrossRefPubMedWeb of Science
  35. 35.↵
    1. Hanifin JM,
    2. Reed ML
    ; Eczema Prevalence and Impact Working Group. A population-based survey of eczema prevalence in the United States. Dermatitis 2007;18:82–91.
    OpenUrlCrossRefPubMedWeb of Science
Back to top

In this issue

Print
Download PDF
Article Alerts
Email Article
Citation Tools

Jump to section

Keywords